Life Science Zurich Impact Conference

Date

26.05.2025 09:00 - 19:00

Application date

09.05.2025

Location

Technopark, Technoparkstrasse 1, 8005 Zurich

Register

Follow this Link

Life Science Zurich Impact «Precision Medicine and AI Innovations» is a one-day multi-track meeting that provides a platform for scientists from academia and industry to present their projects to potential collaborators and investors thus stimulating a dialogue between research, healthcare and economy with a focus on translational medicine.

The future of precision medicine and artificial intelligence (AI) is poised to revolutionize healthcare by providing more personalized, efficient, and effective treatments. The convergence of precision medicine and AI holds great promise for transforming healthcare. However, significant technical, ethical, and logistical challenges must be overcome to realize these benefits. Against this backdrop, the aim of the conference is to discuss the opportunities and challenges in the field, and to demonstrate how AI and precision medicine are advancing our knowledge and helping to solve challenging health problems.

Format

The conference will feature keynote speakers, parallel sessions, one-to-one partner meetings and an industry exhibition. The parallel sessions will cover topics such as diagnostics, drug and therapy developments, gender medicine, and technology platforms.

Target audience

Participants from academia, clinics and pharma, biotech, medtech, digital health and IT companies (research, business development, startups, in-licensing), corporate funds and venture capitalists are expected to participant.

Swiss Venture Capital Report TEST

The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". You can download it in our assets section.